EQS-News: SphingoTec GmbH: Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)

Issuer: SphingoTec GmbH / Key word(s): Agreement/Contract Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid) 15.11.2022

Related Keywords

Germany ,India ,Hennigsdorf ,Brandenburg ,Gangwon ,Kangwon Do ,South Korea ,China ,Indonesia ,Berlin ,Republic Of Korea ,Kostenloser Wertpapierhandel ,Sphingotec Gmbh ,Eui Yul Choi ,Sphingotec Gmb ,Ruxandra Lenz ,Boditech Med Inc ,Clin Chem Lab ,Distribution Services ,Adm ,Yul Choi ,Boditech Med ,Rev Dis Primers ,Early Biomarker ,Septic Acute Kidney Injury ,Septic Shock ,Kidney Int ,Chem Lab ,New Biomarker ,Pediatric Acute Kidney Injury ,Children Under One Year ,Clin Chem Lab Med ,Tec Gmbh ,Corporate News ,Regulatory Announcements ,News ,Sphingotec ,Mbh ,Boditech ,Close ,Lobal ,Icensing ,Agreement ,Kidney ,Junction ,Biomarker ,Roenkephalin ,Enkid ,